Trimethoprim-sulfamethoxazole (Q68829712)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498863%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

title

Trimethoprim-sulfamethoxazole (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498863%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

F R Cockerill

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498863%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

R S Edson

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498863%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

publication date

1 October 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498863%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498863%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498863%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498863%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

page(s)

921-929

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498863%20AND%20SRC:MED&resulttype=core&format=json

Sulphamethoxazole-trimethoprim: the first two years

27 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Resistance to trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. Implication of folinic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Absorption and Urinary Execretion of Trimethoprim, Sulfamethoxazole, and Trimethoprim-Sulfamethoxazole: Results with Single Doses in Normal Young Adults and Preliminary Observations during Therapy with Trimethoprim-Sulfamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Clinical Pharmacology of Intravenously Administered Trimethoprim-Sulfamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Diffusion of Antibiotics from Plasma into Prostatic Fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Observations on Activity of Trimethoprim-Sulfamethoxazole in the Prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Ventricular cerebrospinal fluid concentrations of trimethoprim-sulphamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Pharmacokinetics of Trimethoprim and Sulfamethoxazole in Normal Subjects and in Patients with Renal Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Trimethoprim with Sulfamethoxazole for Treatment of Infection with Pneumocystis carinii in Renal Insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Trimethoprim-sulfamethoxazole: pharmacodynamic effects of urinary pH and impaired renal function. Studies in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae. Report of a study group on bacterial resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Single-dose therapy with trimethoprim-sulfamethoxazole for urinary tract infection in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Treatment of cystitis in women with a single dose of trimethoprim-sulfamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Prophylaxis of recurrent urinary tract infection in female patients. Efficacy of low-dose, thrice-weekly therapy with trimethoprim-sulfamethoxazole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Effect of Treatment Regimens forNeisseria gonorrhoeaeon Simultaneous Infection withChlamydia trachomatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Salmonella typhi in vivo acquires resistance to both chloramphenicol and co-trimoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Antibiotics in the Treatment of Gastroenteritis Caused by Enteropathogenic Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Quantitative Inhibition of Haemophilus influenzae by Trimethoprim/Sulfamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Comparison of trimethoprim-sulfamethoxazole with ampicillin in acute infectious exacerbations of chronic bronchitis: a double-blind crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Intravenous trimethoprim-sulfamethoxazole therapy for Pneumocystis carinii pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Successful Chemoprophylaxis forPneumocystis cariniiPneumonitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Trimethoprim-Sulfamethoxazole Therapy for Nocardia Infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Disk diffusion susceptibility testing of Nocardia species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Trimethoprim/sulfamethoxazole-resistant Nocardia asteroides causing multiple hepatic abscesses. Successful treatment with ampicillin, amikacin, and limited computed tomography-guided needle aspiration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Cotrimoxazole Prophylaxis in Patients With Leukemia and Prolonged Granulocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Acute Brucellosis Treated with Trimethoprim and Sulphamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Trimethoprim-sulphamethoxazole in acute brucellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

A Comparative Study of Legionella micdadei and Other Nosocomial Acquired Pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Failure of erythromycin in treatment of Legionella micdadei pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Trimethoprim-Sulfamethoxazole for Bacterial Meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Wegener's granulomatosis: observations on treatment with antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

Oral or intravenous trimethoprim-sulfamethoxazole therapy for shigellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

7 January 2021

In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

7 January 2021

Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

7 January 2021

Adverse reactions to trimethoprim-sulfamethoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965049-6

7 January 2021

10.1016/S0025-6196(12)65049-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498863%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498863%20AND%20SRC:MED&resulttype=core&format=json